Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control.
Jon-Duri SennStefan FischliLea SlahorSusanne SchelbertChristoph HenzenPublished in: Journal of clinical medicine (2019)
In people with T1D and unsatisfactory diabetes control the introduction of CSII and CGM results in a substantial and long-term improvement.